Quotes 5-day view End-of-day quote Shenzhen Stock Exchange
10/20/2020
10/21/2020
10/22/2020
10/23/2020
10/26/2020
Date
144.83
141.9
137.96
132.83
134.57
Last
3222111
4151027
4519670
4483368
3304436
Volume
+0.23% -2.02% -2.78% -3.72% +1.31% Change
Sales 2020
7 276 M 1 088 M 1 088 M
Net income 2020
2 327 M 348 M 348 M
Net Debt 2020
-
-
-
P/E ratio 2020
22,8x
Yield 2020
0,12%
Sales 2021
5 134 M 768 M 768 M
Net income 2021
1 129 M 169 M 169 M
Net Debt 2021
-
-
-
P/E ratio 2021
47,1x
Yield 2021
0,05%
Capitalization
52 614 M 7 868 M 7 871 M
Capi. / Sales 2020
7,23x
Capi. / Sales 2021
10,2x
Nbr of Employees
-
Free-Float
99,0%
BGI Genomics Co., Ltd. is a China-based company principally engaged in the diagnosis and research of genomics. The Company's main products and services include reproductive health basic research and clinical application services, basic science research services (genome sequencing, bioinformatics analysis and other multithreaded solutions), complex disease basic research and clinical application services, as well as...
Notations Surperformance© of BGI Genomics Co., Ltd.
Trading Rating : Investor Rating : -
All news about BGI GENOMICS CO., LTD.
News in other languages on BGI GENOMICS CO., LTD.
Chinese listed companies ramp up virus efforts after president's call
Chart BGI GENOMICS CO., LTD.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends BGI GENOMICS CO., LTD.
Short Term Mid-Term Long Term Trends Bearish Neutral Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
3
Average target price
Last Close Price
132,83
Spread / Highest target
-
Spread / Average Target
-
Spread / Lowest Target
-
Please enable JavaScript in your browser's settings to use dynamic charts.
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report
